
Sign up to save your podcasts
Or


Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations).
Click here to see the study
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Docs Who Lift4.7
378378 ratings
Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations).
Click here to see the study
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

575 Listeners

3,782 Listeners

333 Listeners

141 Listeners

48 Listeners

106 Listeners

1,639 Listeners

1,200 Listeners

244 Listeners

217 Listeners

364 Listeners

85 Listeners

168 Listeners

14 Listeners

44 Listeners